Corpus Intelligence IC Memo — GOLETA VALLEY COTTAGE HOSPITAL 2026-04-26 15:51 UTC
IC Memo — GOLETA VALLEY COTTAGE HOSPITAL
Investment Committee Memorandum | CA | 24 beds | Grade C | EBITDA uplift $8.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

GOLETA VALLEY COTTAGE HOSPITAL

CCN 050357 | SANTA BARBARA, CA | 24 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

GOLETA VALLEY COTTAGE HOSPITAL is a 24-bed suburban community hospital in SANTA BARBARA, CA with $111.9M in net patient revenue and a 14.8% operating margin. The hospital serves a payer mix of 46.4% Medicare, 3.0% Medicaid, and 50.6% commercial.

Thesis: Turnaround. Our ML models identify $8.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 14.8% to 22.1% (+736bps).

Net Revenue HCRIS$111.9M
Current EBITDA COMPUTED$16.5M
Operating Margin COMPUTED14.8%
Occupancy HCRIS28.1%
Revenue / Bed COMPUTED$4.7M
Net-to-Gross HCRIS34.2%
Distress Probability ML48.8%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
63
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 14.8% places it above the state median. Among 63 size-comparable peers (12-48 beds), the median margin is -9.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-48), prioritizing same-state peers. 63 hospitals in the comp set.

HospitalStateBedsRevenueMargin
GOLETA VALLEY COTTAGE HOSPITAL (Target)CA24$111.9M14.8%
TAHOE FOREST HOSPITALCA25$264.3M13.0%
PORTERVILLE DEVELOPMENTAL CENTCA17$193.6M-6.0%
SUTTER DAVIS HOSPITALCA48$176.9M12.5%
ADVENTIST HEALTH CLEARLAKECA25$159.9M-6.3%
RIDGECREST REGIONAL HOSPITALCA25$149.6M-14.7%
HAZEL HAWKINS MEM. HOSPITALCA25$141.1M-16.7%
FAIRCHILD MEDICAL CENTERCA25$109.4M-0.3%
SUTTER COAST HOSPITALCA39$107.9M2.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.4M+210bp18mo
Cost to Collect4.5%2.5%$2.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.4M+122bp9mo
Clean Claim Rate88.0%96.0%$72K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.4M
Cost to Collect
$2.2M
Denial Rate Reduction
$2.2M
A/R Days Reduction
$1.4M
Clean Claim Rate
$72K
Total EBITDA Uplift$8.2M
Current EBITDA$16.5M
+ RCM Uplift+$8.2M
Pro Forma EBITDA$24.8M
Current Margin14.8%
Pro Forma Margin22.1%
WC Released (1x)$4.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$25.4M$191.3M7.53x49.8%
Base (11x exit)10.0x11.0x$25.4M$218.7M8.61x53.8%
Bull Case9.0x11.0x$22.9M$254.1M11.11x61.9%
Bull (12x exit)9.0x12.0x$22.9M$284.0M12.42x65.5%
Bear Case11.0x10.0x$27.9M$141.9M5.08x38.4%
Bear (11x exit)11.0x11.0x$27.9M$165.1M5.91x42.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 28.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 63 hospitals with 12-48 beds
  • Same-state prioritization (n=64)
  • Comp margins: P25=-19.6% / P50=-9.9% / P75=-0.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.